Erratum for Ramasamy and Subbian,“critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis”

S Ramasamy, S Subbian - Clinical microbiology reviews, 2021 - Am Soc Microbiol
Volume 34, no. 3, e00299-20, 2021, https://doi. org/10.1128/CMR. 00299-20. Page 7, Fig. 1
legend, line 1:“Interaction of cellular pathways and networks for cytokine induction and IFN …

Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis

S Ramasamy, S Subbian - Clinical microbiology reviews, 2021 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19), a rapidly evolving pandemic worldwide with at least 68 million …

Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins

Y Lu, HA Michel, PH Wang, GL Smith - Frontiers in Microbiology, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the
current coronavirus disease 2019 (COVID-19) pandemic, induces an unbalanced immune …

Correction: the signal pathways and treatment of cytokine storm in COVID-19

L Yang, X Xie, Z Tu, J Fu, D Xu, Y Zhou - Signal transduction and …, 2021 - nature.com
After online publication of the article, 1 the editor noticed that Figs. 1 and 4 were produced
with the assistance of Servier Medical Art (https://smart. servier. com) without citation. The …

Interferon induction, evasion, and paradoxical roles during SARS‐CoV‐2 infection

C Chiale, TT Greene, EI Zuniga - Immunological Reviews, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative agent of
coronavirus disease 2019 (COVID‐19), has caused millions of deaths in the past two years …

[HTML][HTML] Host transcriptional response to SARS‐CoV‐2 infection in COVID‐19 patients

NK Singh, S Srivastava, L Zaveri, TC Bingi… - Clinical and …, 2021 - ncbi.nlm.nih.gov
Dear Editor, COVID-19 has an extremely variable prognosis, ranging from asymptomatic
and mildly affected individuals to severe disease and death. We have investigated the …

[PDF][PDF] SARS-CoV-2 is sensitive to type I interferon pretreatment

KG Lokugamage, A Hage, C Schindewolf, R Rajsbaum… - BioRxiv, 2020 - scienceopen.com
Abstract 1 SARS-CoV-2, a novel coronavirus (CoV), has recently emerged causing an
ongoing outbreak of 2 viral pneumonia around the world. While genetically distinct from the …

Weak induction of interferon expression by severe acute respiratory syndrome coronavirus 2 supports clinical trials of interferon-λ to treat early coronavirus disease …

TR O'Brien, DL Thomas, SS Jackson… - Clinical Infectious …, 2020 - academic.oup.com
Coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus,
was first identified in the Hubei province of China in December 2019 and has now spread …

[HTML][HTML] SARS-CoV-2 spike antagonizes innate antiviral immunity by targeting interferon regulatory factor 3

RS Freitas, TF Crum, K Parvatiyar - Frontiers in Cellular and Infection …, 2022 - frontiersin.org
Corona virus disease 2019 (COVID-19) pathogenesis is intimately linked to the severe acute
respiratory syndrome corona virus 2 (SARS-CoV-2) and disease severity has been …

[HTML][HTML] SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon

M Shemesh, TE Aktepe, JM Deerain, JL McAuley… - PLoS …, 2021 - journals.plos.org
Type I Interferons (IFN-Is) are a family of cytokines which play a major role in inhibiting viral
infection. Resultantly, many viruses have evolved mechanisms in which to evade the IFN-I …